๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Growth rates of small cell bronchogenic carcinomas

โœ Scribed by Brian A. Brigham; Paul A. Bunn Jr.; John D. Minna; Martin H. Cohen; Daniel C. Ihde; Stanley E. Shackney


Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
929 KB
Volume
42
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Chemoimmunotherapy of small cell broncho
โœ Paul Y. Holoye; Melvin L. Samuels; Terry Smith; Joseph G. Sinkovics ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 426 KB ๐Ÿ‘ 2 views

Thirty-one patients with small cell bronchogenic carcinoma were treated with a regimen of cyclophosphamide, Adriamycin and vincristine. Padiotherapy was given to patients with limited disease. Nonspecific immunotherapy consisting of BCG scarification was administered after each chemotherapy course.

The growth rate of bronchogenic carcinom
โœ William Weiss ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 362 KB ๐Ÿ‘ 2 views

Six patients with bronchogenic carcinomas presenting as solitary nodules had from seven to nine serial chest roentgenograms which permitted measurement of tumor diameters in the absence of definitive therapy. Growth curves were plotted simultaneously on semilogarithmic and arithmetic coordinates to

Benefits of polychemotherapy in advanced
โœ Yvon Cormier; Dollard Bergeron; Jacques La Forge; Michel Lavandier; Marcien Four ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 377 KB ๐Ÿ‘ 2 views

The benefits of polychemotherapy in advanced (Stage 111) non-small-cell bronchogenic carcinoma remain uncertain. In attempt to answer the important question whether treatment improves well-being and survival in these patients, we did a prospective, randomized, single-blind study to compare polychemo